| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 9.7e-05 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 4.6e-05 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -2.1e-05 | 1 |